The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII
about
malonyl CoA-acyl carrier protein transacylasemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putativemalonyl CoA-acyl carrier protein transacylase, putative
P1343
Equal opportunity for low-degree network nodes: a PageRank-based method for protein target identification in metabolic graphs1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH)Malonyl-CoA: acyl carrier protein transacylase fromHelicobacter pylori: Crystal structure and its interaction with acyl carrier proteinPlasmodium falciparumacyl carrier protein crystal structures in disulfide-linked and reduced states and their prevalence during blood stage growthThe suf iron-sulfur cluster synthesis pathway is required for apicoplast maintenance in malaria parasitesMembrane transporters in the relict plastid of malaria parasitesThe Plasmodium falciparum PfGatp is an endoplasmic reticulum membrane protein important for the initial step of malarial glycerolipid synthesisTropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplastMass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthaseThe amidase domain of lipoamidase specifically inactivates lipoylated proteins in vivo.Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents.Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysisTargeting the Lipid Metabolic Pathways for the Treatment of Malaria.Apicoplast and endoplasmic reticulum cooperate in fatty acid biosynthesis in apicomplexan parasite Toxoplasma gondii.'FAS't inhibition of malaria.Parasite plastids: approaching the endgame.The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs.Chemoenzymatic exchange of phosphopantetheine on protein and peptideCelastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.Novel antimalarial drug targets: hope for new antimalarial drugs.Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering.Lactococcus lactis fabH, encoding beta-ketoacyl-acyl carrier protein synthase, can be functionally replaced by the Plasmodium falciparum congener.A high yield optimized method for the production of acylated ACPs enabling the analysis of enzymes involved in P. falciparum fatty acid biosynthesis.Babesia bovis: a bipartite signal directs the glutamyl-tRNA synthetase to the apicoplast.Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis.Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates.In vivo functional analyses of the type II acyl carrier proteins of fatty acid biosynthesis.Host biotin is required for liver stage development in malaria parasites.Deorphanization of Malonyl CoA:ACP Transacylase Drug Target in Plasmodium falciparum (PfFabD) Using Bacterial Antagonists: A 'Piggyback' Approach for Antimalarial Drug DiscoveryAntioxidant Metabolism, Photosystem II, and Fatty Acid Composition of Two Tall Fescue Genotypes With Different Heat Tolerance Under High Temperature Stress
P2860
Q56584715-0B47BA40-8452-41F1-832A-DCE7A14E4E0AQ56737264-8317B2FA-5E3E-483F-8F3E-06D87D67487EQ59758608-3C4CBC01-1D99-4DE8-9B20-5EB2F6EE8965Q59891158-4827A4F1-38F7-41C8-803C-31A62A353063Q59922165-6A01AAF0-5277-4F35-B6B1-666CA4F0E55AQ60002294-A14A6CD1-1081-467B-B09C-5F3EE595A7B2Q60003199-7EA70B16-3469-4815-BB7D-D3E84EBD96D0Q60003614-C5990C03-5FF7-428E-BB32-4052CCC2F978Q60011862-97A7CBE9-EC36-4902-8FD8-EA1B6D18394FQ60016742-34986B81-4FB8-49EF-8387-57255BD6D026Q61621174-0B2A56FE-A6BC-4152-8562-8B925F20DF3E
P1343
Q21559702-7493A018-7033-46A1-9A70-35937CB052F4Q24564306-0DB36195-DBFE-4640-ACB9-3E46ED106144Q27644933-4A8FEA30-916C-4911-9631-55812111E45BQ27657492-077F28C8-2E5A-4349-AAA8-5197163C79E0Q27974759-5CC6BA83-B313-46F1-B676-DD4A71F37E15Q30039456-11D4509C-4B95-4506-A10A-336FC865D494Q30041336-46416B79-DFB9-45F9-B853-FD28760E8A88Q30080014-1DBA4717-7180-4857-8B1C-AE1056D338CEQ33283922-6EE704A3-8513-442C-93D8-57CB1C57F7F9Q33509285-ECCF8AA8-44B6-4BB0-9FF1-F08DADA91E6FQ33605124-EBCFC40C-CAF8-40D6-AF7A-392ACE5E11B0Q33679330-420B6320-B205-4219-9BAB-AD9E83A10390Q33915847-E26DB76E-0DBA-4E15-A19B-47EB9DDE96E8Q35762962-39D0C058-B490-4635-B821-D2C270BECA46Q35865145-D2F0885F-6EB8-4A1C-9FFE-5A919744F6D9Q36052586-8FC9F9FA-A030-48FF-890D-E6F4B9CC4D28Q36066272-CA5BE7FE-A438-4343-BD8F-65D9587ACF11Q36695649-A7E259A1-52AE-4AE1-B89E-A17D96C47F69Q36729008-027A598A-12BC-4988-8187-21148B31F21AQ37960187-FCCE0B9A-8B8E-4B73-A324-6F5BF39DC4FEQ38001104-8BFACE00-3795-4623-853A-0A6F595FD8AEQ38264138-FDD4B72F-D5B2-4FB2-8A0B-A5D5B8D50D3DQ41517603-C5F93AC8-35B6-412A-B21D-2167AF55FA7BQ41682590-F61BCD59-2F7B-4830-B8FD-A68E17CC4AFEQ41899796-A758DCB2-587B-4E74-B163-74CB00BD8DABQ42095354-37316254-082A-47BF-8DC3-722BE9522270Q46935191-5F95AB93-E3A7-49D8-82CF-AA152F54D33BQ47833476-EFE1B03B-B3F1-44DD-A0AC-0968B0DB82C1Q50421800-490CFB19-7041-4AD9-BCF5-7B6477EA945BQ56584718-B3C5C707-2C4E-4017-9F76-34213EDDD77BQ58719675-DD4A4F70-A70F-48A7-B86A-ED8F59F79AAE
P2860
The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@ast
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@en
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@nl
type
label
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@ast
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@en
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@nl
prefLabel
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@ast
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@en
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@nl
P2093
P921
P356
P1433
P1476
The initiating steps of a type ...... by pfACP, pfMCAT, and pfKASIII
@en
P2093
Kevin A Reynolds
Lucia Gerena
Norman C Waters
Sean T Prigge
P304
P356
10.1021/BI026847K
P407
P577
2003-02-04T00:00:00Z